Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle called ‘myocarditis’ in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle called ‘myocarditis’ in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.The ministry’s unpublished report produced data on the side effects of the Covid-19 vaccine, raising concerns on the possible link between the second dose and myocarditis cases, particularly in men under 30, Channel 12 reported.Of over five million people who received the vaccine in Israel, around 62 cases of myocarditis were recorded in days after the vaccination, the report said. Furthermore, 56 of these cases arose on administering the second shot and most of the affected were men under 30. Reuters quoted Israeli pandemic response coordinator Nachman Ash as saying that a preliminary study showed ‘tens of incidents’ of myocarditis among the vaccinated individuals primarily after the second dose. Ash added: “The Health Ministry is currently examining whether there is an excess in morbidity and whether it can be attributed to the vaccines.”
